首页> 外文OA文献 >Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models
【2h】

Bioactive scaffolds in stem-cell-based therapies for cardiac repair: protocol for a meta-analysis of randomized controlled preclinical trials in animal myocardial infarction models

机译:基于干细胞的心脏修复疗法中的生物活性支架:动物心肌梗死模型随机控制临床前试验的荟萃分析的方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background Acute myocardial infarction (MI) remains one of the leading causes of death worldwide with no curative therapy available. Stem cell therapies have been gaining interest as a means to repair the cardiac tissue after MI and prevent the onset of heart failure. Many in vivo reports suggest that the use of stem cells is promising, yet clinical trials suggest that the cells fail to integrate into the native tissue, resulting in limited improvements in cardiac function and repair. To battle this limitation, the combination of using stem cells embedded in a bioactive scaffold that promotes cell retention is growing in interest. Yet, a systematic review of the literature on the use of stem cells embedded in bioactive scaffolds for cardiac repair has not yet been performed. In this protocol, we outline a systematic review and meta-analysis of preclinical trials in animal MI models that utilize stem cell-embedded scaffolds for cardiac repair and compare their effects to stem cell-treated animals without the use of a scaffold. Methods/design We will search the following electronic databases: Cochrane Library, MEDLINE, Embase, PubMed, Scopus and Web of Science, and gray literature: Canadian Agency for Drugs and Technologies in Health and Google Scholar. We will only include randomly controlled preclinical trials that have directly investigated the effects of stem cells embedded in a scaffold for cardiac repair in an animal MI model. Two investigators will independently review each article included in the final analysis. The primary endpoint that will be investigated is left ventricular ejection fraction. Secondary endpoints will include infarct size, end systolic volume, end diastolic volume, fractional shortening and left ventricular wall thickness. Pooled analyses will be conducted using the DerSimonian-Laird random effects and Mantel-Haenszel fixed-effect models. Between-studies heterogeneity will be quantified and determined using the Tau2 and I 2 statistics. Publication bias will be assessed using visual inspection of funnel plots and complemented by Begg’s and Egger’s statistical tests. Possible sources of heterogeneity will be assessed using subgroup-meta analysis and meta-regression. Discussion To date, the use of scaffolds in myocardial repair has not yet been systematically reviewed. The results of this meta-analysis will aid in determining the efficacy of stem cell-embedded scaffolds for cardiac repair and help bring this therapy to the clinic.
机译:摘要背景急性心肌梗死(MI)仍然是全世界死亡原因之一,没有可用治疗方法。干细胞疗法是兴趣作为修复MI后修复心脏组织并防止心力衰竭开始的手段。许多体内报告表明,使用干细胞是有前途的,但临床试验表明细胞未结合到天然组织中,导致心功能和修复的有限改善。为了使这种限制进行这种限制,使用嵌入生物活性支架中的干细胞的组合促进细胞保留的兴趣。然而,尚未进行对嵌入生物活性支架中的干细胞的文献的系统审查尚未进行心脏修复。在本方案中,我们概述了一种系统的审查和荟萃分析,对动物MI模型的临床前试验,利用干细胞嵌入支架进行心脏修复,并将它们的效果与使用支架进行了对干细胞处理的动物的影响。方法/设计我们将搜索以下电子数据库:Cochrane图书馆,Medline,Embase,PubMed,Scopus和Web,以及灰色文学:加拿大卫生和谷歌学者的药物和技术机构。我们将仅包括随机控制的临床前试验,该试验直接研究了在动物MI模型中嵌入支架中的干细胞的效果。两名调查员将独立审查最终分析中包含的每篇文章。将研究的主要终点是左心室喷射部分。次要终点将包括梗塞大小,最终收缩量,最终舒张压体积,分数缩短和左心室壁厚。将使用Dersimonian-Laird随机效应和Mantel-Haenszel固定效果模型进行汇总分析。研究之间的内致性将量化和使用Tau2和I 2统计量化和确定。将使用漏斗图的目视检查评估出版物偏见,并通过BEGG和EGGER的统计测试补充。使用亚组 - Meta分析和Meta-返回评估可能的异质性来源。迄今为止,尚未系统地审查了在心肌修复中使用支架。该荟萃分析的结果将有助于确定干细胞嵌入式支架用于心脏修复的疗效,并帮助将该疗法带到诊所。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号